A randomized phase III study of immune checkpoint inhibition with chemotherapy in treatment-naive metastatic anal cancer patients: A trial of the ECOG-ACRIN cancer research group (EA2176) Meeting Abstract


Authors: Roth, M. T.; Catalano, P. J.; Ciombor, K. K.; Benson, A. B.; Yao, X.; Yaeger, R.; Salem, M. E.; Morris, V. K.; Henry, D. H.; Whisenant, J. G.; O'Dwyer, P. J.; Eng, C.
Abstract Title: A randomized phase III study of immune checkpoint inhibition with chemotherapy in treatment-naive metastatic anal cancer patients: A trial of the ECOG-ACRIN cancer research group (EA2176)
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120306242
DOI: 10.1200/JCO.2021.39.15_suppl.TPS3614
PROVIDER: wos
Notes: Meeting Abstract: TPS3614 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rona Denit Yaeger
    315 Yaeger
Related MSK Work